14. Chronic inflammatory demyelinating polyneuropathy Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 175 / Drugs : 161 - (DrugBank : 41) / Drug target genes : 13 - Drug target pathways : 24
Chronic inflammatory demyelinating polyneuropathy and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
ID | Diseases (Sorted by score) | Score |
---|---|---|
14 | Chronic inflammatory demyelinating polyneuropathy | - |
13 | Multiple sclerosis/Neuromyelitis optica | 12.000 |
11 | Myasthenia gravis | 8.704 |
6 | Parkinson disease | 4.192 |
12 | Congenital myasthenic syndrome | 3.467 |
50 | Dermatomyositis | 2.387 |
3 | Spinal muscular atrophy | 2.358 |
222 | Primary nephrotic syndrome | 2.322 |
28 | Systemic amyloidosis | 2.304 |
49 | Systemic lupus erythematosus | 2.211 |
4 | Primary lateral sclerosis | 1.895 |
83 | Addison disease | 1.875 |
61 | Autoimmune hemolytic anemia | 1.760 |
331 | Idiopathic multicentric castleman disease | 1.677 |
66 | IgA nephropathy | 1.638 |
60 | Aplastic anemia | 1.587 |
65 | Primary immunodeficiency | 1.452 |
85 | Idiopathic interstitial pneumonia | 1.441 |
96 | Crohn disease | 1.397 |
2 | Amyotrophic lateral sclerosis | 1.395 |
46 | Malignant rheumatoid arthritis | 1.391 |
43 | Microscopic polyangiitis | 1.232 |
300 | IgG4-related disease | 1.200 |
44 | Wegener granulomatosis | 1.071 |
35 | Pemphigus | 1.057 |
52 | Mixed connective tissue disease | 1.000 |
220 | Rapidly progressive glomerulonephritis | 1.000 |
30 | Distal myopathy | 1.000 |